25227-0
Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mL
Active
Part Description
LP16294-8 Tobramycin
Tobramycin sulfate is an aminoglycoside antibiotic produced by Streptomyces tenebrarius used to treat various bacterial infections, particularly Gram-negative infections. It works by binding to a site on the bacterial ribosome, causing the genetic code to be misread. Like all aminoglycosides, tobramycin does not pass the gastro-intestinal tract, so for systemic use it can only be given intravenously or intramuscularly. This formulation for injection is branded Nebcin®. Patients with cystic fibrosis will often take an inhalational form (Tobi®) for suppression of Pseudomonas aeruginosa infections. Tobramycin is also combined with dexamethasone as an ophthalmic solution (TobraDex®). Bausch Lomb Pharmaceuticals, Inc. makes a sterile Tobramycin Ophthalmic Solution (eye-drops) with a tobramycin concentration of 0.3%. In the USA it is available by prescription only.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
Tobramycin (Wikipedia)
LOINC Names Get Info
- Fully-Specified Name
- Tobramycin:
Susc: Pt: Isolate: OrdQn: Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mL - Long Common Name
- Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mL
- Short Name
- Tobramycin Islt Slgr Mcbct AB 10.0
- Display Name
- Tobramycin Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mL [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Tobramycin
Part Model Get Info
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.82 (NAM)
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41123-7 | TobramycinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Tobramycin 10,0 ug/mL: |
| de-DE | German (Germany) | Tobramycin: |
| el-GR | Greek (Greece) | Τομπραμυκίνη 10,0 ug/mL: Synonyms: 10,0 ug/mL ABXBACT OrdQn Pt Susc Απομονωμένο στέλεχος Μέθοδος για βραδέως αναπτυσσόμενα μυκοβακτηρίδια Τομπραμυκίνη |
| es-AR | Spanish (Argentina) | tobramicina 10 ug/ml: |
| es-ES | Spanish (Spain) | Tobramicina 10 ug/mL: |
| es-MX | Spanish (Mexico) | Tobramicina 10,0 ug / mL: |
| fr-BE | French (Belgium) | Tobramycine 10,0 mg/L: |
| fr-FR | French (France) | Tobramycine 10mg/L: |
| fr-CA | French (Canada) | Tobramycine, 10,0 mg/L: |
| it-IT | Italian (Italy) | Tobramicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 토브라마이신 10.0ug/mL: |
| nl-NL | Dutch (Netherlands) | tobramycine 10,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Tobramicina 10.0 ug/ml: Synonyms: NEBCIN; |
| tr-TR | Turkish (Turkey) | Tobramisin 10.0 ug/mL: |
| zh-CN | Chinese (China) | 妥布霉素 10.0 微克/毫升: Synonyms: 10 ug/mL; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://